We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Conduent
CNDT
$264M
| $3.97M | ﹤0.01% |
1,662,111
+129,045
| +8% | +$300K |
|
2027
TotalEnergies
TTE
$190B
| $3.97M | ﹤0.01% |
103,175
-84
| -0.1% | -$3.11K |
|
2028
Strategy Inc
MSTR
$38.4B
| $3.96M | ﹤0.01% |
334,320
-50,780
| -13% | -$618K |
|
2029
Olin
OLN
$2.12B
| $3.94M | ﹤0.01% |
342,850
-44,210
| -11% | -$563K |
|
2030
Deluxe
DLX
$1.15B
| $3.93M | ﹤0.01% |
166,850
+319
| +0.2% | +$8K |
|
2031
Dine Brands
DIN
$452M
| $3.92M | ﹤0.01% |
93,113
+20,970
| +29% | +$847K |
|
2032
Frontline
FRO
$8.85B
| $3.91M | ﹤0.01% |
+560,444
| New | +$4.76M |
|
2033
Stewart Information Services
STC
$2.08B
| $3.91M | ﹤0.01% |
120,227
+18,501
| +18% | +$557K |
|
|
SHOE
2034
Shoe Station Group
SHOE
$428M
| $3.91M | ﹤0.01% |
267,010
-262,968
| -50% | -$3.14M |
|
2035
Univest Financial
UVSP
$1.18B
| $3.9M | ﹤0.01% |
241,824
+13,041
| +6% | +$209K |
|
|
PETQ
2036
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $3.9M | ﹤0.01% |
111,927
+30,193
| +37% | +$847K |
|
2037
Matador Resources
MTDR
$6.09B
| $3.9M | ﹤0.01% |
458,189
-17,652
| -4% | -$123K |
|
2038
1st Source
SRCE
$2.12B
| $3.89M | ﹤0.01% |
109,301
+8,287
| +8% | +$274K |
|
2039
NVE Corp
NVEC
$609M
| $3.88M | ﹤0.01% |
62,794
-7,340
| -10% | -$420K |
|
2040
Interparfums
IPAR
$3.94B
| $3.88M | ﹤0.01% |
80,535
-19,449
| -19% | -$876K |
|
2041
Seaboard Corp
SEB
$4.06B
| $3.87M | ﹤0.01% |
1,318
-140
| -10% | -$424K |
|
|
TBIO
2042
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.87M | ﹤0.01% |
215,810
+77,288
| +56% | +$1.17M |
|
|
FSCT
2043
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $3.86M | ﹤0.01% |
182,166
+8,938
| +5% | +$243K |
|
2044
Southside Bancshares
SBSI
$967M
| $3.86M | ﹤0.01% |
139,271
+10,818
| +8% | +$307K |
|
|
LTHM
2045
DELISTED
Livent Corporation
LTHM
| $3.85M | ﹤0.01% |
625,416
+15,998
| +3% | +$101K |
|
2046
Kelly Services Class A
KELYA
$528M
| $3.83M | ﹤0.01% |
242,295
+47,395
| +24% | +$678K |
|
2047
Invesco Mortgage Capital
IVR
$805M
| $3.79M | ﹤0.01% |
101,473
+23,403
| +30% | +$805K |
|
2048
Tompkins Financial
TMP
$1.42B
| $3.79M | ﹤0.01% |
58,435
-40,818
| -41% | -$2.66M |
|
|
EVOP
2049
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $3.78M | ﹤0.01% |
165,666
+1,127
| +0.7% | +$22.4K |
|
2050
Ribbon Communications
RBBN
$383M
| $3.78M | ﹤0.01% |
960,937
+88,645
| +10% | +$322K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.